Skip to main content
Clinical Trials/JPRN-UMIN000002918
JPRN-UMIN000002918CompletedPhase 4

Study on efficacy and safety of aggressive antihypertensive therapy and its effect on QOL - S-CATS(Saga Challenge AntihyperTensive Study)

Saga hypertension treatment study group0 sites200 target enrollmentStarted: December 18, 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Patients with secondary hypertension 2) Patients with cardiac failure (NYHA grade III or IV) 3) Pregnant patients, including one trying to conceive pregnancy during the planned study period 4) Patients with severe liver dysfunction 5) Patients with renal failure (serum creatinine ≥2.0 mg/dL) 6) Patients with a history of hypersensitivity to ingredients of losartan or HCTZ 7) Patients with a history of hypersensitivity to thiazide or thiazide-like diuretics 8) Patients who are considered not eligible for the study by the attending doctor due to medical reasons

Investigators

Sponsor
Saga hypertension treatment study group

Similar Trials